Skip to main content
NCBI home page
Cellular and Molecular Neurobiology logoLink to Cellular and Molecular Neurobiology
. 2001 Oct;21(5):465–475. doi: 10.1023/A:1013863205647

Regulation of Corticotropin-Releasing Hormone (CRH) Transcription and CRH mRNA Stability by Glucocorticoids

Xin-Ming Ma 1, Cheri Camacho 1, Greti Aguilera 1
PMCID: PMC11533839  PMID: 11860185

Abstract

1. The increases in corticotropin-releasing hormone (CRH) mRNA following long-term adrenalectomy are associated with low levels of CRH gene transcription, suggesting that glucocorticoids regulate CRH mRNA at the posttranscriptional level. In this study we determined the time course of transcriptional activation after early adrenalectomy by intronic in situ hybridization, and evaluated the effects of glucocorticoids on CRH mRNA stability.

2. Plasma corticosterone was undetectable 3 h after adrenalectomy, but CRH hnRNA increased only by 12 h, and remained elevated for the next 72 h. CRH mRNA increased 18 h after adrenalectomy and reached a plateau lasting from 2 to 6 days, despite very low CRH hnRNA levels.

3. Assessment of CRH mRNA stability, by incubation of slide-mounted hypothalamic sections in an intracellular-like medium at 37°C, prior to measuring CRH mRNA levels by in situ hybridization, revealed a half-life (t 1/2) of 11.5 min in sham-operated rats, and a slower decrease adrenalectomized rats (t 1/2-26.3 min). Corticosterone administration for 3 days markedly decreased CRH mRNA t 1/2in both sham-operated and adrenalectomized rats (6.5 and 5.0 min, respectively).

4. The data show that adrenalectomy causes transient increases in CRH mRNA transcription, followed by decreases in the rate of CRH mRNA degradation. This suggests that glucocorticoids regulate CRH mRNA at two sites, by inhibiting transcription and by decreasing mRNA stability.

Keywords: corticotropin-releasing hormone, hypothalamic paraventricular nucleus, transcription, mRNA stability, glucocorticoids, adrenalectomy

REFERENCES

  1. Aguilera, G. (1998). Corticotropin releasing hormone, receptor regulation and the stress response. Trends Endocrinol. Metab. 9: 329-336. [DOI] [PubMed] [Google Scholar]
  2. Beyer, H. S.,Matta, S. G., andSharp, B. M. (1988). Regulation of the messenger ribonucleic acid for corticotropin releasing factor in the paraventricular nucleus and other brain regions. Endocrinology123: 2117-2123. [DOI] [PubMed] [Google Scholar]
  3. Brown, E. R., andSawchenko, P. E. (1997). HypophysiotropicCRFneurons display a sustained immediateearly gene response to chronic stress but not to adrenalectomy. J. Neuroendocrinol. 9: 307-316. [DOI] [PubMed] [Google Scholar]
  4. Carranza, E. J.,Pasieka, K. B., andMajzoub, J.A. (1988). The vasopressinmRNApoly(A) tract is unusually long and increases during stimulation of vaopressin gene expression in vivo. Mol. Cell. Biol.8: 2267-2274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Carter, D. A., andMurphy, D. (1989). Independent regulation of neuropeptide mRNA level and poly(A) tail length. J. Biol. Chem.264: 6601-6603. [PubMed] [Google Scholar]
  6. Cooper, J. A.,Fuller, J. M.,McMinn, K. M., andCulbreth, R. R. (1998). Modulation of monocyte chemotactic protein-1 production by hyperoxia: Importance of mRNA stability in control of cytokine production. Am. Respir. Cell. Mol. Biol. 18: 521-525. [DOI] [PubMed] [Google Scholar]
  7. Herman, J. P.,Schafer, M. K.,Thompson, R.C., andWatson, S. J. (1992). Rapid regulation of corticotropinreleasing hormone gene transcription in vivo. Mol. Endocrinol. 6: 1061-1069. [DOI] [PubMed] [Google Scholar]
  8. Imaki, T.,Wang, X.-Q.,Shibasaki, T.,Yamada, K.,Harada, S.,Chikada, N.,Naruse, M., andDemura, H. (1995). Stress induced activation of neuronal activity and corticotropin-releasing factor gene expression in the paraventricular nucleus is modulated by glucocorticoid in rats. J. Clin. Invest.96: 231-328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Iredale, P. A., andDuman, R. S. (1997). Glucocorticoid regulation of corticotropin releasing factor-1 receptor expression in pituitary-derived AtT-20 cells. Mol. Pharmacol.51: 794-799. [DOI] [PubMed] [Google Scholar]
  10. Jingami, H.,Matsukura, S.,Numa, S., andImura H. (1985). Effects of adrenalectomy and dexamethasone administration on the levels of prepro-corticotropin releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/B-lipotropin processor mRNA in the pituitary in rats. Endocrinology117: 1314-1320. [DOI] [PubMed] [Google Scholar]
  11. Kovacs, K.,Kiss, J. Z., andMakara, G. B. (1986). Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of corticotropin releasing factor and arginine vasopressin immunostaining induced by adrenalectomy. Neuroendocrinology44: 229-234. [DOI] [PubMed] [Google Scholar]
  12. Kren, B. T.,Trembley, J. H., andSteer, C. J. (1996). Alterations in mRNA stability during rat liver regeneration. Am. J. Physiol.270: G763-G777. [DOI] [PubMed] [Google Scholar]
  13. Lightman, S. L., and Young,W. S. (1989). Influence of steroids on the hypothalamic corticotropin releasing factor and proenkephalin mRNA responses to stress. Proc. Natl. Acad. Sci. USA86: 4306-4310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Luo, X.,Kiss, A.,Makara, G. B.,Lolait, S. J., andAguilera, G. (1994). Stress-specific regulation of corticotropin releasing hormone receptor expression in the paraventricular and supraoptic nuclei of the hypothalamus in the rat. J. Neuroendocrinol. 6: 689-696. [DOI] [PubMed] [Google Scholar]
  15. Ma, X.-M., andAguilera G. (1999a). Transcriptional responses of the vasopressin and corticotropin releasing hormone genes to acute and repeated intraperitoneal hypertonic saline injection. Mol. Brain Res.68: 129-140. [DOI] [PubMed] [Google Scholar]
  16. Ma, X.-M., andAguilera, G. (1999b). Differential regulation of corticotropin releasing hormone and vasopressin transcription by glucocorticoids. Endocrinology140: 5642-5650. [DOI] [PubMed] [Google Scholar]
  17. Ma, X.-M.,Levy, A., andLightman, S. L. (1997). Rapid changes of heteronuclear RNA for arginine vasopressin but not for corticotropin releasing hormone in response to acute corticosterone administration. J. Neuroendocrinol. 9: 723-728. [DOI] [PubMed] [Google Scholar]
  18. Mahonen, A.,Jukkola, A.,Risteli, L.,Risteli, J., andMaenpaa, P. H. (1998). Type I procollagen synthesis is regulated by steroids and related hormones inhumanosteosarcoma cells. J. Cell. Biochem. 68: 151-163. [PubMed] [Google Scholar]
  19. Mozo, L.,Gayo, A.,Suarez, A.,Rivas, D.,Zamorano, J., andGutierrez, C. (1998). Glucocorticoids inhibit Il-4 and mitogen-induced IL-4R alpha chain by different post-transcriptional mechanisms. J. Allergy Clin. Immunol.102: 968-976. [DOI] [PubMed] [Google Scholar]
  20. Nickenig, G., andMurphy, T. J. (1996). Enhanced angiotensin receptor type-1 mRNA degradation and induction of polyribosomal mRNA binding proteins by angiotensin II in vascular smooth muscle cells. Mol. Pharmacol.50: 743-751. [PubMed] [Google Scholar]
  21. Ochedalski, T.,Rabadan-Diehl, C., andAguilera, G. (1998). Interaction between glucocorticoids and corticotropin releasing hormone in the regulation of pituitary CRH receptor in vivo in the rat. J. Neuroendocrinol. 10: 363-369. [DOI] [PubMed] [Google Scholar]
  22. Robinson, B. G.,Frim, D. M.,Schwartz, W. J., andMajzoub, J. A. (1988). Vasopressin mRNA in suprachiasmatic nuclei: Daily regulation of polyadenylate tail length. Science241: 342-344. [DOI] [PubMed] [Google Scholar]
  23. Sacks, A. B. (1993). Messenger RNA degradation in eukaryotes. Cell74: 413-421. [DOI] [PubMed] [Google Scholar]
  24. Sawchenko, P. E. (1997). Evidence for a local site of action for glucocorticoids in inhibiting CRF and vasopressin expression in the paraventricular nucleus. Brain Res.403: 213-224. [DOI] [PubMed] [Google Scholar]
  25. Swanson, L. W., andSimmonds, D. M. (1989). Differential steroid hormone and neural influence on peptide mRNA levels in CRH cells of the paraventricular nucleus: A hybridization histochemistry study in the rat. J. Comp. Neurol. 285: 413-435. [DOI] [PubMed] [Google Scholar]
  26. Vale, W. W.,Rivier, C.,Brown, M. R.,Spiess, J.,Koob. G.,Swanson, L.,Bilezikjian, L.,Bloom, F., andRivier, J. (1983). Chemical and biological characterization of corticotropin releasing factor. Rec. Prog. Horm. Res. 39: 245-270. [DOI] [PubMed] [Google Scholar]
  27. Xu, Z. X., andRooney, S. A. (1997). Glucocorticoids increase fatty acid synthetase mRNA stability in fetal rat lung. Am. J. Physiol. 272: L860-L864. [DOI] [PubMed] [Google Scholar]
  28. Young,W. S.,Mezey, E., andSiegel, R. E. (1986). Quantitative in situ hybridization histochemistry reveals increased levels of corticotropin releasing factor mRNA after adrenalectomy in rats. Neurosci. Lett. 70: 198-203. [DOI] [PubMed] [Google Scholar]

Articles from Cellular and Molecular Neurobiology are provided here courtesy of Springer

RESOURCES